Condition

Prostate Cancer Aggressiveness

ClinicalTrials.gov condition label

Clinical trials4

Recruiting1

Common interventions7

Lead sponsors shown4

Clinical trials

4 shown

Active Surveillance SNEP Assay Registry Trial for Prostate CancerNCT04052048 · 2019-09-09

Artificial Intelligence Models for Precision Prediction and Treatment of Prostate CancerNCT06662708 · 2024-12-01

NOT_YET_RECRUITING

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's ContinuumNCT05384002 · 2021-02-24

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPCNCT03263650 · 2017-10-03

Common interventions

Accurate Prediction Artificial Intelligence ModelsDIAGNOSTIC_TEST1 CabazitaxelDRUG1 CarboplatinDRUG1 Magnetic Resonance ImagingDIAGNOSTIC_TEST1 OlaparibDRUG1 Prednisone 5MgDRUG1 Subtraction Normalized Expression of Phagocytes Blood TestDIAGNOSTIC_TEST1

Leading sponsors

Fondazione del Piemonte per l'Oncologia1 Immunis.AI1 M.D. Anderson Cancer Center1 Shao Pengfei1

Trial status mix

COMPLETED2

NOT_YET_RECRUITING1

RECRUITING1

Phase mix

NA1

PHASE21

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.